Milrinone Lactate In 5% Dextrose Injection, Solution
Product Images NDC 70069-873

This text describes a 100 mL Single-Dose Flexible Container of Milrinone Lactate in 5% Dextrose Injection for intravenous infusion. It provides information on the dosage, storage recommendations, cautionary measures, and manufacturing details. The product is manufactured for Somerset Therapeutics, LLC in Somerset, NJ, and it is noted to be made in India. Recommended storage temperature is 25°C (77°F) with brief exposure up to 40°C (104°F) being acceptable. The solution should be clear, colorless to pale yellow, and must not be used in series connections or administered simultaneously with blood.*

This is a description of Milrinone Lactate in 5% Dextrose Injection, a 100mL Single-Dose Flexible Container meant for intravenous infusion only. Each mL contains 200 mcg (0.2 mg) of milrinone lactate, with 0.282 mg of lactic acid, 54.3 mg of dextrose hydrous and has a pH of 3.5 (3.2 - 4.0). The solution should be clear, colorless to pale yellow, and must be discarded if leaks are found in the container. It should not be used in series connections or administered simultaneously with blood. The product is sterile, nonpyrogenic, and does not contain preservatives. The usual dosage can be found in the package insert, and it should be stored at room temperature, protected from freezing and excessive heat. The product is manufactured in India for Somerset Therapeutics, LLC.*

This is an -generated description of a Milrinone Lactate in 5% Dextrose Injection product. The batch coding area is 73 x 20 mm, and it is recommended to be stored at room temperature. The product is for intravenous infusion only and each 200 mL container contains 40 mg of Milrinone. It is a sterile, nonpyrogenic, single dose, with no preservatives added. The manufacturer is Somerset Therapeutics, LLC in Somerset, NJ. The recommended dosage is intravenously as directed by a physician. It is advised to check for leaks in the container before use, discard if found, and not use in series connections. Additionally, it should not be administered simultaneously with blood and should only be used if the solution is clear, colorless to pale yellow.*

This is a detailed description of a Milrinone Lactate in 5% Dextrose Injection packaged in a single-dose flexible container. It includes information on dosage, storage instructions, manufacturing details, and precautions regarding usage and sterility. The product is intended for intravenous infusion only and should not be used if the overwrap is damaged. The text also mentions the content of each mL of solution and advises to discard any unused portion. Additionally, it states that the product should not be used in series connections and should not be administered simultaneously with blood.*